EHC Stock Analysis

Analyzing Encompass Health Corp (EHC): An Educational Research Review

Welcome to this detailed stock research review of Encompass Health Corp (EHC). This article is presented as an educational resource by StockValueFinder.com to help investors understand how to evaluate a company using a disciplined, metric-driven approach. Rather than relying on intuition or market hype, we use a systematic screening process to determine if a company meets specific benchmarks for profitability, solvency, and valuation.

Encompass Health Corp operates within the Healthcare sector, specifically in the Medical Care Facilities industry. For the purpose of this review, we will examine the company's current financial standing based on the StockValueFinder screening system, which evaluates the balance between a company's quality and its current price.

Why the StockValueFinder Score Matters

The StockValueFinder system assigns a numerical score to stocks to provide a quick snapshot of how many fundamental "tests" a company has passed. For Encompass Health Corp (EHC), the current score is 67%.

In our educational framework, a score of 67% indicates that the company passes a majority of the fundamental screens but fails in a few key areas. This is why the current rating is listed as "REVIEW." A "REVIEW" rating suggests that while the company possesses several strengths, there are specific metrics—often related to valuation or debt—that require closer inspection before a disciplined investor would consider the stock a "perfect" fit for a value-oriented portfolio.

The goal of this score is to remove emotion from investing. Instead of asking "Do I like this company?" the investor asks "Does this company meet the mathematical requirements for safety and value?"

EPS Strength and Consistency

The first pillar of our analysis is Earnings Per Share (EPS) strength. EPS represents the portion of a company's profit allocated to each outstanding share of common stock. It is a primary indicator of a company's ability to generate profit for its shareholders.

For Encompass Health Corp, the system recorded the EPS test as "Passed." While the specific historical EPS figures were not supplied for this report, the "Passed" status indicates that the company's earnings trajectory meets the system's requirements for consistency and growth.

**Educational Insight: Why EPS Consistency Matters** Consistency in earnings is often more important than a single year of explosive growth. A company that grows earnings steadily year-over-year is generally more predictable and less risky than a company with volatile earnings that swing from profit to loss.

*Example:* Imagine Company A has EPS of $1.00, $1.10, and $1.20 over three years. Imagine Company B has EPS of $0.50, $2.00, and -$0.20 over three years. Even if Company B had one "great" year, Company A is the more attractive candidate because its consistency allows for more accurate future modeling.

ROIC and Capital Efficiency

Return on Invested Capital (ROIC) is one of the most critical metrics for determining if a management team is skilled at allocating capital. It measures how much profit a company generates for every dollar of capital (debt and equity) it puts to work.

Encompass Health Corp has an ROIC of 10.99%.

**Evaluating the ROIC Range** StockValueFinder generally prefers an ROIC of 10% or higher. - **Attractive Range:** 10% to 20%+ (Indicates efficient use of capital). - **Weak Range:** Below 10% (Indicates the company may be struggling to generate a meaningful return on its investments).

Because EHC’s ROIC of 10.99% is above the 10% threshold, it passed the ROIC test. This suggests that the company is effectively turning its invested capital into profit.

*Example:* If Company X has an ROIC of 15% and Company Y has an ROIC of 4%, Company X is significantly more efficient. Company X earns 15 cents for every dollar invested, while Company Y only earns 4 cents. Over time, the company with the higher ROIC typically creates more shareholder value.

Interest Coverage and Financial Safety

Before looking at total debt, we look at interest coverage. This metric tells us how easily a company can pay the interest on its outstanding debt using its operating earnings. It is a measure of immediate financial survival.

The system marked the Interest Coverage test for Encompass Health Corp as "Passed."

**Educational Insight: The Interest Coverage Benchmark** StockValueFinder prefers an interest coverage ratio of 6 or higher. This provides a significant "margin of safety," ensuring that even if earnings drop temporarily, the company can still service its debt without facing bankruptcy.

*Example:* If a company has $6 million in earnings and $1 million in interest payments, its coverage is 6x. If it has $2 million in earnings and $1 million in interest payments, its coverage is only 2x. The 6x company is much safer during an economic downturn.

Debt Payback and Balance Sheet Discipline

While interest coverage looks at the *immediate* ability to pay interest, the Debt Payback test looks at the *long-term* ability to eliminate the principal debt. This is calculated by dividing the total debt by the annual free cash flow.

Encompass Health Corp has a debt payback period of 5.57 years. Consequently, the company did not pass the Debt Payback test.

**Evaluating the Debt Payback Range** StockValueFinder prefers a debt payback period of 3 years or less. - **Attractive Range:** 0 to 3 years (The company could theoretically clear its debt quickly). - **Weak Range:** Over 5 years (The company is carrying a heavier debt load relative to its cash flow).

With a payback period of 5.57 years, EHC is carrying more debt than the system considers ideal for a high-discipline value screen.

*Example:* If Company A can pay off all its debt in 1.5 years using its cash flow, it is in a position of extreme strength. If Company B takes 7 years to pay off its debt, it is more vulnerable to rising interest rates or a decline in revenue.

P/E Ratio and Valuation Discipline

A company can be high-quality, but if the stock price is too high, the investment can still be poor. This is where the Price-to-Earnings (P/E) ratio comes in. The P/E ratio tells us how much the market is willing to pay for every $1 of earnings.

Encompass Health Corp has a P/E ratio of 20.75. Because of this, the company did not pass the P/E valuation test.

**Evaluating the P/E Range** For valuation discipline, StockValueFinder prefers a P/E of 15 or lower. - **Value Range:** 15 or lower (The stock is potentially undervalued or fairly priced). - **Expensive Range:** Over 20 (The market has priced in significant future growth, leaving less room for a "bargain").

At 20.75, EHC is trading at a premium compared to the system's strict value threshold.

*Example:* If Company X has a P/E of 8 and Company Y has a P/E of 40, and both have similar growth rates, Company X is the more value-oriented choice. You are paying $8 for every $1 of profit in Company X, versus $40 for the same profit in Company Y.

Moving Average Trend and Entry Timing

Fundamental analysis tells us *what* to buy, but technical trends help us understand *when* to buy. We use moving averages to identify the current momentum of the stock price.

Encompass Health Corp currently shows a "STRONG BUY TREND." However, the entry signal, limit buy idea, pullback zone, and risk stop levels are all listed as "N/A."

**Educational Insight: Trend vs. Entry** It is important to distinguish between a trend and an entry signal. A "Strong Buy Trend" means the stock price is currently moving upward in a healthy pattern. However, this is not a signal that the stock *must* continue to rise, nor is it a recommendation to buy at the current price.

The "N/A" status for the pullback zone and limit buy idea means the system has not identified a specific, discounted price point for entry at this time. Disciplined investors often wait for a "pullback"—a temporary drop in price during an uptrend—to enter a position rather than buying at the peak of a trend.

Overall Financial Strengths and Weaknesses

To summarize the data for Encompass Health Corp (EHC), we can categorize the results into strengths and weaknesses based on the StockValueFinder benchmarks.

**Strengths:** - **Profitability:** The company passed the EPS and ROIC tests, with an ROIC of 10.99%, indicating a capable management team and a functional business model. - **Immediate Solvency:** The company passed the interest coverage test, meaning it can comfortably handle its current interest payments. - **Momentum:** The stock is currently in a "Strong Buy Trend," showing positive market sentiment.

**Weaknesses:** - **Long-term Debt:** With a debt payback period of 5.57 years, the company exceeds the preferred 3-year limit. - **Valuation:** A P/E ratio of 20.75 is higher than the preferred 15 or lower, suggesting the stock is not currently in the "value" zone.

Risks and Limitations

Every investment carries risk. For EHC, the primary risks identified by these metrics are valuation and leverage. When a stock has a P/E over 20, it is more susceptible to a price correction if the company fails to meet growth expectations. Additionally, while the company can cover its interest, the 5.57-year payback period indicates a reliance on debt that could become a burden if the healthcare industry faces systemic headwinds or if interest rates rise significantly.

Educational Conclusion

Encompass Health Corp (EHC) presents a profile of a fundamentally sound company that is currently trading at a premium. With a StockValueFinder score of 67%, it passes the tests for earnings consistency, capital efficiency (ROIC), and interest coverage. However, it fails the tests for debt payback and P/E valuation.

For a student of value investing, EHC serves as a perfect example of the difference between a "good company" and a "good value." A company can be highly profitable and trending upward, but if the price (P/E) is too high and the debt (Payback) is too long, it may not meet the strictest criteria for a value investment.

This research process encourages investors to look past the "Strong Buy Trend" and examine the underlying balance sheet to ensure that the price they pay is justified by the company's financial health.

"This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security."

Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings